Cargando…
287 Genomic and Immunologic Characterization of Lung Adenocarcinoma in Never Smokers vs. Smokers
OBJECTIVES/GOALS: Smoking is a well-established risk factor for lung cancer, but never smokers account for up to 25% of lung cancer cases. There is mounting evidence that lung cancer in never smokers is biologically distinct. We aim to characterize the genomic and immunologic features of lung adenoc...
Autores principales: | Li, P. Jonathan, Tsui, Jessica, Ding, Vivianne W., Combes, Alexis J., Krummel, Matthew F., Jablons, David M., Kratz, Johannes R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129691/ http://dx.doi.org/10.1017/cts.2023.343 |
Ejemplares similares
-
Genetic and immunologic features of recurrent stage I lung adenocarcinoma
por: Kratz, Johannes R., et al.
Publicado: (2021) -
Distinct immune microenvironment of lung adenocarcinoma in never-smokers from smokers
por: Luo, Wenxin, et al.
Publicado: (2023) -
Intratumoral Heterogeneity and Immune Modulation in Lung Adenocarcinoma in Female Smokers and Never Smokers
por: Trefzer, Timo B., et al.
Publicado: (2022) -
Genomic Aberrations in Lung Adenocarcinoma in Never Smokers
por: Job, Bastien, et al.
Publicado: (2010) -
Lung cancer in never smokers: Tumor immunology and challenges for immunotherapy
por: de Alencar, Viviane Teixeira L., et al.
Publicado: (2022)